Overview
Preoperative clearance, chest pain triage, and exercise stress testing all rely on structured scoring systems that turn a mix of vital signs, history, and test results into a single number a clinical team can act on quickly. This guide covers seven such tools spanning three related clinical scenarios: ruling pulmonary embolism in or out before imaging, deciding whether a hospitalized or surgical patient needs blood-thinning prophylaxis or closer monitoring, and interpreting an exercise stress test.
This content is educational, not medical advice. Every score below is a decision-support instrument meant to be used alongside a clinician's complete assessment of a patient — vital signs, imaging, lab values, and history that a calculator alone can't capture. A low-risk score reduces probability; it does not eliminate it, and a high-risk score identifies a population-level pattern that may or may not apply the same way to any single patient. If you're using these tools to understand your own results, bring them to a conversation with a qualified healthcare provider rather than acting on them independently.
The seven scores are grouped by how they're actually used in practice: two pulmonary embolism screening tools, one hospital-admission thromboprophylaxis score, one preoperative cardiac risk score, and three tools used around exercise stress testing and stent management.
Step 1: Estimate Pulmonary Embolism Probability with the Revised Geneva Score
The Revised Geneva Score estimates the pretest probability of pulmonary embolism (PE) using only objective, standardized clinical variables — no subjective judgment calls required, which is what sets it apart from the Wells Score. It weighs eight factors: age over 65 (1 point), previous DVT or PE (3 points), surgery or a fracture within the past month (2 points), active malignancy (2 points), unilateral leg pain (3 points), hemoptysis (2 points), heart rate (3 points for 75–94 bpm, 5 points for 95 bpm or higher), and pain on lower-limb palpation with unilateral edema (4 points).
Total scores fall into three categories: low probability (0–3 points), intermediate probability (4–10 points), and high probability (11 or more points). Because every input is a fact from the chart or exam rather than an impression, two different clinicians assessing the same patient are more likely to arrive at the same Geneva score than the same Wells score — a reproducibility advantage that matters when a patient is being handed off between providers. Like other PE pretest probability tools, the resulting category guides whether D-dimer testing alone is sufficient or whether imaging (typically CT pulmonary angiography) should be ordered directly.
The Revised Geneva Score Calculator totals each weighted factor automatically and shows the resulting probability category, making it easy to see which specific finding is contributing the most points.
Step 2: Rule Out Pulmonary Embolism Without Testing Using PERC
The Pulmonary Embolism Rule-out Criteria (PERC) exist for one specific situation: a patient a clinician has already judged to be low pretest probability for PE, where the goal is deciding whether any further testing is even needed. PERC checks eight binary criteria — age under 50, heart rate under 100, oxygen saturation of 95% or higher, no prior DVT or PE, no recent trauma or surgery, no hemoptysis, no exogenous estrogen use, and no unilateral leg swelling.
If all eight criteria are negative in a genuinely low-probability patient, the false-negative rate for PE is low enough that many protocols support stopping the workup there, avoiding both D-dimer testing and its downstream imaging cascade. If even one criterion is positive, PERC cannot be used to exclude further testing — the workup continues with D-dimer or imaging as clinically indicated. The rule was specifically designed to reduce unnecessary CT scans in low-risk patients, not to screen higher-risk patients, and using it outside a low pretest probability population invalidates its statistical basis.
The PERC Calculator walks through all eight criteria and gives a clear PERC-negative or PERC-positive result along with a count of which criteria were met.
Step 3: Assess Hospital-Acquired Blood Clot Risk with the Padua Prediction Score
The Padua Prediction Score estimates venous thromboembolism (VTE) risk in hospitalized medical patients — as distinct from surgical patients — to decide who needs pharmacologic thromboprophylaxis during admission. It weighs eleven factors with different point values: active cancer (3 points), previous VTE (3 points), reduced mobility (3 points), a known thrombophilic condition (3 points), recent trauma or surgery within a month (2 points), and six factors worth 1 point each — age 70 or older, heart or respiratory failure, acute myocardial infarction or ischemic stroke, acute infection or a rheumatologic disorder, obesity with a BMI of 30 or higher, and ongoing hormonal treatment.
A total score of 4 or higher classifies a patient as high-risk, which typically prompts pharmacologic prophylaxis such as low-molecular-weight heparin unless a bleeding risk factor makes that inadvisable. A score below 4 is considered low-risk, where mechanical measures like compression stockings are often favored instead, since the clotting risk doesn't clearly outweigh the bleeding risk of anticoagulation. The score was derived and validated specifically in general medical ward patients, so it isn't intended for surgical or ICU populations, which have their own dedicated risk tools.
The Padua Score Calculator lists all eleven criteria individually so you can see which specific factors are pushing a patient into the high-risk category.
Step 4: Estimate Surgical Cardiac Risk with the Gupta Perioperative Risk Score
The Gupta Myocardial Infarction or Cardiac Arrest (MICA) score estimates the percentage risk that a patient will have a heart attack or cardiac arrest within 30 days of a noncardiac surgery. It uses five inputs: age, functional status (independent versus needing some or total assistance with daily activities), ASA physical status class (a standard 1-through-5 anesthesia risk classification), kidney function (normal, mildly impaired, or dependent on dialysis), and the type of surgery planned, since risk varies substantially between, say, a low-risk outpatient procedure and major vascular surgery.
Unlike point-based scores that sort patients into a handful of risk bands, Gupta MICA was built from a large multi-institution surgical database using logistic regression, so it outputs a continuous percentage risk rather than a category — for example, a 0.4% risk versus a 3.1% risk, rather than "low" versus "high." This makes it easier to have a specific, numeric risk conversation with a patient before surgery, though the model's accuracy still depends on entering the correct surgery type, since that single input carries substantial weight in the underlying regression.
The Gupta Risk Calculator converts your five inputs directly into a percentage risk and a corresponding risk band, and it's often used alongside the Revised Cardiac Risk Index for a fuller preoperative risk picture.
Step 5: Interpret an Exercise Stress Test with the Duke Treadmill Score
The Duke Treadmill Score combines three findings from a standard exercise treadmill test into a single risk-stratifying number: total exercise time in minutes, the maximum ST-segment deviation observed on ECG during the test (in millimeters), and an angina index describing whether chest discomfort occurred (0 for none, 1 for non-limiting angina that didn't stop the test, 2 for limiting angina that did). The formula subtracts weighted penalties for ST deviation and angina from the exercise time: score = exercise time − (5 × ST deviation) − (4 × angina index).
Scores of +5 or higher fall into the low-risk category, associated with excellent long-term survival in the original validation cohort; scores from −10 to +4 are moderate risk; and scores of −11 or lower are high risk, often prompting further evaluation such as cardiac catheterization rather than continued medical management alone. Because the formula weights ST-segment changes and angina severity more heavily than raw exercise time, two patients who exercised for the same duration can land in very different risk categories depending on what happened physiologically during the test.
The Duke Treadmill Score Calculator takes your three inputs and returns both the numeric score and its risk category, making it easier to see how each component contributed to the final result.
Step 6: Track Myocardial Oxygen Demand with the Rate Pressure Product
The rate pressure product (RPP), sometimes called the double product, is a simple bedside estimate of how hard the heart is working, calculated as heart rate multiplied by systolic blood pressure. It's used most often during exercise stress testing, where a rising RPP tracks increasing myocardial oxygen demand as exercise intensity increases, and comparing the RPP at the point symptoms or ECG changes appear can help characterize a patient's ischemic threshold.
There's no single universal "dangerous" RPP value — healthy individuals can reach high values during peak exertion without any issue, while a patient with significant coronary artery disease might develop symptoms at a comparatively low RPP. What matters clinically is the value at which a specific patient's symptoms, ECG changes, or blood pressure response occur, tracked over time as a personal reference point rather than compared against a fixed population cutoff. A typical resting RPP in a healthy adult falls in a moderate range, rising substantially with physical exertion or emotional stress.
The Rate Pressure Product Calculator computes RPP instantly from heart rate and systolic blood pressure and shows it against the typical resting reference range for context.
Step 7: Decide on Extended Antiplatelet Therapy with the DAPT Score
The DAPT score helps guide a specific post-stent decision: whether to continue dual antiplatelet therapy (aspirin plus a P2Y12 inhibitor) beyond the standard 12 months after coronary stent placement, or to stop at the standard duration. It weighs nine factors, several of which subtract points — age 75 or older subtracts 2 points, age 65 to under 75 subtracts 1 point — while others add points: current smoking, diabetes, an MI at presentation, a prior PCI or prior MI, a stent diameter under 3mm, and paclitaxel-eluting stent each add 1 point, while congestive heart failure or a low ejection fraction and a saphenous vein graft PCI each add 2 points.
A total score of 2 or higher suggests the ischemic benefit of continuing dual antiplatelet therapy is likely to outweigh the added bleeding risk, based on the trial data the score was derived from, favoring extended therapy. A score below 2 suggests the opposite balance, favoring stopping at the standard 12-month mark. This is a decision made in partnership with a cardiologist, since it weighs a recurring ischemic event against a bleeding event — two very different kinds of harm that don't reduce to a single number without clinical judgment.
The DAPT Calculator totals all nine factors and shows the resulting score alongside its general recommendation direction.
Key Terms
- Pretest Probability — the estimated likelihood of a diagnosis before a confirmatory test is ordered, used to decide which test (if any) makes sense next
- Thromboprophylaxis — preventive treatment, usually a blood thinner or mechanical device, given to reduce the risk of a blood clot forming
- ASA Physical Status Class — a standard 1-to-5 classification of a patient's overall health used to estimate anesthesia and surgical risk
- Ejection Fraction — the percentage of blood pumped out of the heart's main pumping chamber with each contraction, used as a marker of heart function
- ST-Segment Deviation — a change in a specific portion of the ECG waveform that can indicate reduced blood flow to the heart muscle
- Dual Antiplatelet Therapy (DAPT) — the combined use of aspirin and a second platelet-blocking medication, typically after a coronary stent is placed
- Venous Thromboembolism (VTE) — the umbrella term for blood clots that form in a vein, including deep vein thrombosis and pulmonary embolism